A National Academies of Science panel is nearly done evaluating research institutions with a critical eye on the quality of undergraduate education.
A National Academies of Science panel is nearly done evaluating research institutions with a critical eye on the quality of undergraduate education.
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
With an eye to understanding animal regeneration, Alejandro Sánchez Alvarado has turned a freshwater planarian into a model system to watch.
To save money, an Iowa university will shut down its natural history museum and K–12 teacher-training center.
UPenn has filed suit against the president of the Memorial Sloan-Kettering Cancer Center for failing to share intellectual property he developed while at the university.
Funding only outstanding researchers is increasing the gap between good and great labs and forcing some out of science in search of a bigger paycheck.
For the first time researchers have demonstrated the molecular tango that gives rise to repeating patterns in developing animal embryos.
Researchers with millions of grant dollars may face greater scrutiny by the funding agency.